Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEEFBURGER: Beta-blocker Deprescription Post-CABG
NCT04788186Phase 4Unknown
- Sponsor
- University of Saskatchewan
- Start
- Aug 2021
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carvedilol in coronary artery disease (CAD), sponsored by University of Saskatchewan. Status: unknown.
02
Drugs
carvedilol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04788186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04788186.